PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain.

Saved in:
Bibliographic Details
Title: PMS21 Cost Analysis of Work and Household Productivity Improvements with Certolizumab Pegol in Patients with NON-Radiographic Axial Spondyloarthritis in Spain.
Authors: Ferrando, R.1 (AUTHOR), Echave, M.2 (AUTHOR), Espinoza Cámac, N.2 (AUTHOR), Maratia, S.3 (AUTHOR), Casado, M.Á.2 (AUTHOR)
Source: Value in Health. 2020 Supplement 2, Vol. 23, pS596-S596. 1p.
Database: Academic Search Ultimate
Description
ISSN:10983015
DOI:10.1016/j.jval.2020.08.1152